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Summan The controversial issue of enhanced pancreatic carcinogenesis follolwing partial gastrectomy has
been explored in male Wistar rats (n = 40) weighing 250-300 g. Animals were randomised to receive either
60% distal gastrectomy With Roux-en-Y reconstruction or gastrotomy and resuture (control). Immediately
after operation each group was further divided into two subgroups, receiving i.p. injections of either saline or
azaserine (30 mg kg-' wk' for 3 weeks). At 15 months blood was obtained at 0. 5. 15 and 30 min after a fatty
meal for cholecystokinin (CCK) assay: rats were then killed. Pancreatic wet weight was measured, and
histological sections were examined for atypical acinar cell foci (AACF). the putative precursor lesion of
carcinoma. There were no significant differences in body weight or pancreatic weight between controls and rats
with gastrectomy. Only azaserine-treated rats had acidophilic AACF. Partial gastrectomy substantially in-
creased the number of acidophilic AACF per pancreas (median 26.05 vs 2.09: P<0.005), with a 9-fold
increase in their volume (P<0.005). Basal and postprandial plasma CCK concentrations were higher after
gastrectomy than in controls (P<0.05). Partial gastrectomy has an enhancing effect on azaserine-induced
pancreatic carcinogenesis. probably by means of increased CCK release.
Since carcinoma of the pancreas is so difficult to cure and its
aetiology remains obscure. it is important to investigate
potential risk factors such as partial gastrectomy. Several
reports have indicated an increased incidence of pancreatic
cancer in patients undergoing gastric resection (Ross et al..
1982: Mack et al.. 1986: Caygill et al.. 1987: Offerhaus et al..
1987: Mills et al.. 1988: Tersmette et al.. 1990). but other
work is contradictory (Maringhini et al.. 1987: Tomaszewska
& Stachura. 1988: Vecchia et al.. 1990). The former
popularity of partial gastrectomy for treating peptic ulcer
disease. often in young patients. means that there are many
patients alive today who could be at risk of cancer of the
pancreas as well as cancer in the gastric stump (Schrumpf et
al.. 1977).
In the alimentary canal. carcinogenesis can be enhanced by
luminal factors acting directly on the mucosa to produce
hyperplasia (Rainey et al.. 1984; Houghton et al.. 1987). but
in the pancreas any such influence seems to be exerted
indirectly through humoral and or neural mechanisms.
Cholecystokinin (CCK) promotes pancreatic carcinogenesis
in the rat-azaserine model, in which the population of
atypical acinar cell foci (AACF) of acidophilic type reflects
the ultimate number of malignant tumours. Long-term
administration of exogenous CCK increases the number of
these preneoplastic AACF (Douglas et al.. 1989a). and the
CCK antagonist CR-1409 blocks this effect (Douglas et al..
1989b). The promoting effect of pancreatobiliary diversion
on experimental pancreatic carcinogenesis may also be
mediated through a sustained increase in circulating CCK
(Stewart et al.. 1991. Watanapa et al.. 1991). Although par-
tial gastrectomy does not increase fasting levels of CCK in
man or the rat, the CCK response to ingested fat is markedly
greater in both species (Hopman et al.. 1984; Inoue et al..
1987; Malfertheiner et al.. 1987).
We have tested the hypothesis that partial gastrectomy
enhances expenrmental pancreatic carcinogenesis. using
quantitative estimation of AACF to show early malignant
change and measuring CCK secretion to determine its
intermediary role. We avoided any independent effect of
duodenogastric reflux. which may itself enhance pancreatic
carcinogenesis (unpublished data), by using Roux-en-Y re-




Male Wistar rats (n = 40) weighing 250-300 g were housed
in groups of five in animal quarters with a 12 h day night
cycle. Standard pelleted rat food (Paterson and the
Christopher Hill Group. Porton - diet PRD) and water were
freely available. After 1 week of acclimatisation. animals
were randomised to receive either 60% distal gastrectomy or
gastrotomy and resuture (controls). Immediately after the
operation. half the animals in each group were further ran-
domised to receive saline or azaserine (see below). Food was
reintroduced 12 h postoperatively. After overnight fasting, all
rats were killed at 15 months after operation. Imme-diately
before death rats were anaesthesised and a catheter was
inserted into the inferior vena cava. Blood samples (2 ml) for
CCK assay were obtained at 0. 5, 15 and 30 min after a fatty
test meal comprising 3 ml soybean oil. 1 ml glucose solution
(40%). 2 ml water and 0.4 g protein (Maxipro. Scientific
Hospital Supplies. Liverpool. UK). The test meal was infused
through a catheter placed just beyond the pylorus (in con-
trols) or the gastric anastomosis (in rats with gastrectomy).
The position of this catheter was chosen to avoid any effect
of altered gastric emptying. Similar amounts of normal saline
were infused intravenously to maintain the animals until the
end of the test-meal study. After death. the pancreas was
excised and trimmed free of adherent fat and lymph nodes.
The wet weight of each gland was recorded before fixation in
10% buffered neutral formalin. Before immersion in the
fixative solution. each pancreas was spread out on a piece of
porous paper to ensure maximal transectional sectioning.
Operations (Figure 1)
Partial gastrectomy was performed by removal of the distal
60% of the stomach. Gastrojejunostomy was carnred out in a
Roux-en-Y fashion with a 15 cm Roux loop of jejunum
(roughly corresponding to the 45 cm loop usually created in
man). Control rats received a gastrotomy, consisting of a
1 cm incision in the greater curvature of the stomach, which
was immediately resutured. Operations were carried out
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Gastrotomy (control) Partial gastrectomy
Figure 1 Operations performed: 60°o distal gastrectomy with
Roux-en-Y anastomosis and gastrotomv with resuture (control).
Int.. Bristol). using an algon'thm based on that of Campbell
et al. (Campbell et al.. 1982) and modified by Pugh et al..
(Pugh et al.. 1983). Details of this analysis have been alreadv
described in our previous studies (Stewart et al.. 1991).
Statistical analhsis
Student's t-test for unpaired data was used for the group
analysis of plasma CCK concentrations. The levels were
expressed as means (SEM). Median values and ranges were
quoted for body weight, pancreatic weight and quantitative
estimation of AACF. Statistical analysis of these parameters
were performed using Kruskal-Wallis one-way analysis of
variance and the Mann-Whitney U-test.
Results
under light ether anaesthesia, and a continuous 6 0 silk
suture was used for anastomoses.
Carcinogen
Azasenine (Sigma Chemical Company. UK) was dissolved in
0.9'0o NaCl to give a 2.50o solution and wvas administered by
weekly i.p. injection into each rat. startinz immediately after
operation and continuing for the next 2 weeks. The dosage
regime was 30mgkg-'wk-'. giving a total dose of 90mg
kg-<. Controls received 1.2 ml kg-' of 0.9°"O NaCl by weeklv
I.p. injection.
CCK assay
Plasma CCK peptides were extracted from venous blood
samples with C18 'SepPak' cartridges (Waters. Harrow. UK)
(Eysellein et al.. 1987). and eluates were dried by centrifugal
evaporation (Savant, Famingdale. NY. USA).
CCK was measured by a specific radioimmunoassay based
on antiserum A. raised by immunising a rabbit with natural
porcine CCK-33 (donated by Professors V. Mutt and S.R.
Bloom). Antiserum A2 (1:60 000) was incubated at 4'C for 3
days with standard CCK-8 or with plasma samples plus
CCK-8 tracer-labelled with '25iodine (1,000 c.p.m., Amer-
sham. UK) in 0.05 mol 1` sodium phosphate buffer (pH 7.4)
containing 0.25% gelatin and 0.01 mol I` EDTA. Free and
bound tracer were separated by the addition of 6% (weight
volume) charcoal (Norit PN5, BDH. Poole, UK) with 0.6%
(weight volume) dextran. The concentrations of pure peptides
that produced half-maximal inhibition of binding of tracer to
A2 were 2.0 pmol 1' for CCK-8, 2.4 pmol -' for CCK-33,
and 2.2 nmol [I for gastrin 17. The coefficient of variation
within assays was 8.2% and between assays 12.8%. The
sensitivity of the assay (defined as minimal amount of CCK-8
that could be distinguished from zero with 95% confidence)
was 0.2 pmol, and the recovery of CCK-8 and CCK-33
through the SepPak and assay procedure was 79%.
Quantitativ e estimation ofAACF
The pancreas was spread out very thinly and then sectioned
horizontally so that the whole gland could be examined.
Histological sections (5 ftM) of the whole pancreas were
stained with haematoxylin and eosin. coded and scrutinised
'blind'. i.e. the observers did not know what treatment each
animal had received. The atypical acinar cell foci (AACF)
were readily identified and classified as acidophilic or
basophilic according to established criteria (Rao et al.. 1982).
The total area of exocrine pancreatic tissue was measured
directly in a single histological section from each pancreas by
means of a VIDS III video image analyser (Analytical
Measuring Systems, Cambridge). The same instrument was
used to count acidophilic and basophilic AACF and to
measure their transectional area. Data were processed
numerically by the Volugen computer package (InfoResearch
.Mortality, body weight andpancreatic wteight (Table I)
There were five premature deaths from anastomotic leakage
with granuloma formation and intestinal obstruction (two in
gastrectomy-azaserine rats and one in each other group).
Yields of healthy survivors were as follows: control-saline.
nine: control-azaserine. nine: gastrectomry-saline. nine and
gastrectomy-azaserine. eight.
There were no differences in body weight between the four
groups. Although both absolute and relatiVe pancreatic
w-eights of rats With gastrectomy were greater than those of
controls. the differences did not reach a significant level.
Macroscopic examination of the pancreas at autopsy revealed
numerous small white elevated nodules on the surface of the
glands of azaserine-treated animals. particularlv those With
gastnc resection.
Plasma CCK (Figure 2)
Partial gastrectomy increased basal circulating CCK concen-
trations by 46%. Following the test meal. the plasma CCK
response at 5 min in rats with gastrectomy was greater than
in controls (52% vs 41% increments over basal). At 15 and
30 min. plasma CCK levels remained 19% greater than those
of controls, but these differences did not show statistical
significance.
Quantitative analvsis ofAACF
No pancreatic carcinomas were found. Acidophilic AACF.
the putative precancerous lesions, were only seen in
azasenne-treated rats (Table II), whereas a few basophilic
foci appeared in controls as well (Table III). Among
azaserine-treated groups. the observed transectional data
(foci per cm2) revealed a marked increase in incidence of
acidophilic lesions following partial gastrectomy compared
with controls (2.29 vs 0.24). Quantitative stereological
analysis of tissue sections confirmed the dramatic response of
the pancreas to gastric resection with respect to acidophilic
foci. Thus the number of lesions per cc. pancreas was sub-
stantially greater (15.40 vs 1.41), as was the total number of
lesions per pancreas (26.05 vs 2.09). The median diameter of
each lesion was increased by 69% and the volume by a factor
of nine. Moreover, partial gastrectomy enhanced the percen-
tage of the pancreatic volume occupied by acidophilic foci
from 0.09% (control) to 3.38%. With regard to basophilic
AACF, partial gastric resection increased the population of
the lesions only with azaserine treatment, but the gastrecto-
mised animals had fewer foci than the corresponding controls
receiving saline.
Discussion
Partial gastrectomy clearly promoted experimental pancreatic
carcinogenesis, as shown by the very considerable increase in
the number and size of acidophilic AACF. AcidophilicPARTIAL GASTRECTOMY AND PANCREATIC CARCINOGENESIS 385
Table I Body weight. absolute and relative pancreatic weight. Values are median (range)
Control + saline Control + azaserine Gastrectomy + saline Gastrectomy + azaserine
Body weight (g) 502 520 513 512
(355-529) (395-540) (438-527) (343-521)
Absolute pancreatic weight (mg) 1350 1150 1550 1880
(860-3000) (920- 1480) (1000-3000) (800-3550)
Relative pancreatic weight 292.16 234.19 331.05 361.20
(mg/ 100 g body weight) (185.75-567.11) (216.98-278.20) (191.94-573.61) (157.80-1034.98)
Table n Quantitative analysis of acidophilic atypical acinar cell foci (AACF). Values are medians (range)
Control + saline Control + azaserine Gastrectomy + saline Gastrectomy + a-aserine
No. of AACF cm: 0.00 0.24a 0.00 2.29b-d
(0.00- 1.64) (0.39-6.82)
No. of AACF cm' 0.00 1.41' 0.00 ° 5
(0.00- 14.43) (1.63-41.40)
No. of AACF pancreas 0.00 2.09 0.00 26.05b-d
(0.00- 13.27) (4.31-123.37)
Mean focal diameter (jum) 0.00 978.98a 0.00 1650.23b-d
(0.00- 1721.93) (1094.54-2427.36)
Mean focal volume (mm x 100) 0.00 35.52a 0.00 313.10k'
(0.00- 161.65) (147.95-551.96)
Volume as 0o of pancreas 0.00 0.09' 0.00 3.38b-'
(0.00-0.98) (0.90- 16.42)
P 0.05. P <0.001. Significance vs control + saline or gastrectomy + saline groups. cP <0.05. dP <0.005. 'P <0.001.
Significance *s control + azaserine group.
Table II1 Quantitative analysis of basophilic atypical acinar cell foci (AACF). Values are medians (range)
Control + saline Control + azaserine Gastrectomy + saline Gastrectomy + azaserine
No. of AACF cm 0.00 0.00 o.0b 0.12'
(0.00-5.06) (0.00-2.15) (0.00-2.81)
No. of AACF C13 0.00 0.00 °.0ob 2.51a
(0.00-116.51) (0.00-70.16) (0.00-64.48)
No. of AACF pancreas 0.00 0.0 0.00b 2.60k
(0.0- 157.29) (0.00- 103.84) (0.00-103.17)
Mean focal diameter (pm) 0.00 0.00 0.00b 135.00a
(0.00-678.08) (0.00-512.92) (0.00-774.83)
Mean focal volume (mm3 x 100) 0.00 0.00 °°00b 0.28a
(0.00-12.06) (0.00-6.35) (0.00-14.61)
Volume as '00 of pancreas 0.00 0.00 001b 00a
(0.00-0.92) (0.00-0.28) (0.00-0.29)
aP <0.05. Significance vs gastrectomy + saline group. bp <0.05. Significance vs control + saline group.
AACF are well established as the precursors of cancer in this
model (Rao et al., 1982; Roebuck et al., 1984), and they were
only found in rats receiving azaserine. Acidophilic AACF
show considerable growth potential with a mitotic index
(2.75) which greatly exceeds that of basophilic foci (0.125) or
normal pancreas (zero) (Scarpelli et al., 1984). Their in-
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Fire 2 Plasma cholecystokinin levels (pmol 1-) following a
fatty test meal (mean values shown with standard errors of the
mean).
assessment that there were many more macroscopic nodules
on the surface of the pancreas in these rats. We encountered
fewer AACF in all groups compared with Longnecker's
reports (Longnecker et al., 1977; Roebuck et al., 1985) and
our own previous experience (Stewart et al., 1991), probably
because of the relatively large size of rat chosen to facilitate
the gastric operation. Likewise, no actual carcinomas were
found in the pancreas, although Longnecker and Curphey
reported a few of these lesions at 1 year when much younger
rats were given azaserine (Longnecker & Curphey, 1975).
Although quantitative analysis showed that the population of
basophilic foci was also increased in both number and size
after partial gastrectomy, the relevance of this finding is
doubtful since most modulators of the postinitiation phase of
pancreatic carcinogenesis have little effect on basophilic foci
(Roebuck et al., 1982; Roebuck et al., 1985).
Partial gastrectomy alters circulating levels of several gut
peptides, notably gastrin. pancreatic polypeptide and CCK
(Inoue et al.. 1987; Malfertheiner et al., 1987: Rieu et al..
1990). Exogenous gastrin stimulates pancreatic growth (John-
son. 1976), whereas pancreatic polypeptide inhibits pancreatic
secretion (Taylor et al., 1979); the effect of reducing their
circulating levels has not been established in pancreatic car-
cinogenesis. The increase in basal CCK concentrations and
the increased CCK response to a fatty test meal strongly
implicate this peptide as an intermediary in the promoting
effect of partial gastrectomy. The enhanced postprandial
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CCK response is in line with other reports both in man and
the rat (Hopman et al., 1984; Inoue et al.. 1987: Malfer-
theiner et al.. 1987). but unlike other authors we also found a
higher basal level. Previous studies were undertaken either 2
weeks after partial gastrectomy in rats or 1 month after
partial gastrectomy in man: our data suggest that hyper-
cholecystokininaemia persists for up to 15 months and may
even increase with time.
Since direct infusion of the fatty meal into the small bowel
circumvented any variability in gastric emptying. the in-
creased CCK release after partial gastrectomy may be due to
an increased responsiveness of CCK-secreting cells. Diversion
of pancreatobiliary secretions from the jejunal limb of a Roux-
en-Y anastomosis can cause mucosal hyperplasia (Miazza et
al.. 1982). and this hyperplastic response might well involve
the enteroendocrine cells and lead to increased cholecvsto-
kinin production. Lower concentrations of intraluminal
protease have been shown in patients with subtotal gastric
resection in the early phase after a fatty meal (MacGregor et
al.. 1977). Similar protease reduction in the rat might also
contribute to an increased CCK response. since low levels of
intraluminal trypsin are known to stimulate CCK release
(Louie et al.. 1986: Calam et al.. 1987). Although CCK
stimulates pancreatic growth. the fact that there is a loss of
the normal pancreatic response to several tropic hormones
(including CCK) with advancing age (Greenberg et al.. 1986:
Poston et al.. 1991) might explain the non-significant increase
in pancreatic weight 15 months after partial gastrectomy.
Data from an experimental rat model can only be of
tentative relevance to man. Although our rats received a
carcinogen, patients with previous partial gastrectomy have
increased levels of nitrites and n-nitroso compounds in gastric
juice. and these substances can act as pancreatic carcinogens
(Schlag et al.. 1980). Nitrosamines could be absorbed and
subsequently secreted into the pancreatic juice or might reflux
from the duodenum into the pancreatic duct. thereby induc-
ing pancreatic cancer. The combination of increased post-
prandial CCK release and greater exposure to pancreatic
carcinogens might explain the increase in pancreatic cancer
risk after gastrectomy. Our unpublished data showing only a
few acidophilic AACF 6 months after a similar partial zas-
trectomv in rats underline the importance of a long-term
experiment for a clear-cut effect to emerge. They could also
explain why an increased risk of pancreatic cancer in man
only appears to reach statistical significance 20 years after
gastric resection (Cavgill et al.. 1987: Tersmette et al.. 1990).
We thank the Royal Postgraduate Medical School and the Hammer-
smith and Queen Charlotte's Special Health Authority for support-
ing this research.
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